Skip to Content

Tykerb

In the US, Tykerb (lapatinib systemic) is a member of the following drug classes: EGFR inhibitors, HER2 inhibitors and is used to treat Breast Cancer and Breast Cancer - Metastatic.

US matches:

Ingredient matches for Tykerb

Lapatinib

Lapatinib is reported as an ingredient of Tykerb in the following countries:

  • Ecuador
  • Egypt
  • Turkey

Lapatinib ditosylate (a derivative of Lapatinib) is reported as an ingredient of Tykerb in the following countries:

  • Argentina
  • Australia
  • Bangladesh
  • Canada
  • Chile
  • Colombia
  • Hong Kong
  • Indonesia
  • Israel
  • Japan
  • Lebanon
  • Malaysia
  • Mexico
  • New Zealand
  • Oman
  • Peru
  • Philippines
  • Singapore
  • South Africa
  • Taiwan
  • Thailand
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide